20/20 Biolabs, Inc. Common Stock (AIDX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

20/20 Biolabs, Inc. Common Stock (AIDX) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $4.9M, listed on NASDAQ, employing roughly 13 people, carrying a beta of -0.42 to the broader market. 20/20 GeneSystems, Inc. Led by Jonathan Cohen, public since 2023-06-15.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for AIDX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →